Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials |
| BNF code | 0801050Q0AAAEAE |
| Virtual Therapeutic Moiety | Irinotecan pegylated liposomal |
| Abbreviated name | Irinotecan pegylated liposomal 43mg/10ml inf vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 1 May 2021 |
| Previous name | Irinotecan pegylated liposomal 43mg/10ml solution for infusion vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 10.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Irinotecan sucrosofate salt pegylated liposomal |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372538008 |
| Strength value numerator | 4.300 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | dispersioninfusion.intravenous |
| Dose Form | |
| Formulation | Dispersion for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) | |
| Virtual Medicinal Product Packs | |
| Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.